Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives-Reference-Cited by-同舟云学术

Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives

Published:2023-06 Issue: Volume:186 Page:104013
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

de Scordilli Marco,Michelotti Anna,Zara Diego,Palmero Lorenza,Alberti Martina,Noto Claudia,Totaro Fabiana,Foltran Luisa,Guardascione Michela,Iacono Donatella,Ongaro Elena,Fasola Gianpiero,Puglisi Fabio

Funder

Ministero della Salute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference106 articles.

1. Neoadjuvant chemotherapy switch in borderline resectable/locally advanced pancreatic cancer;Alva-Ruiz;Ann. Surg. Oncol.,2021

2. Genomic analyses identify molecular subtypes of pancreatic cancer;Australian Pancreatic Cancer Genome Initiative;Nature,2016

3. The role of tumor cell–derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth;Bennewith;Cancer Res.,2009

4. Safety and activity of Anti–PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med,2012

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J. Clin. Oncol.,1997

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of Research Progress on Borderline Resectable Pancreatic Cancer: A Bibliometric and Visualized Analysis;Journal of Digestive Cancer Research;2024-04-20

2. Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus;Cancers;2023-07-19